RegulationPrimary source

Abbott Agrees to Pay Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products

Abbott Agrees to Pay Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products

What happened

Abbott Agrees to Pay Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products

Why it matters

The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.

Affected entities

View evidence

1 reports · 1 original report · 1 independent

  1. U.S. Department of JusticePrimary source · Supports · EN · 100%
    Abbott Agrees to Pay Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products

Claims

  • Abbott Agrees to Pay Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products Observed

Conflicts

No material conflict detected in the available evidence.

Timeline

  1. First reported

Market move following event

Market reaction is not yet available for this asset and time window.

Score explanation

Confidence · formula confidence-2.1.0
Source trust97
Independent corroboration51
Primary evidence100
Claim consistency82
Extraction confidence82
Attribution quality90
Impact · formula impact-2.1.0
Event magnitude45
Market relevance88
Entity significance42
Market breadth45
Novelty68
Urgency52
capital magnitude100
Ranking · formula rank-1.0.0
Confidence factor0.9235
Freshness factor0.9051
Breaking bonus0